Device Shoulder - Suture - Fiberwire - Cerclage

Shoulder Suture Fiberwire Cerclage

Payments companies reported to CMS as associated with Shoulder Suture Fiberwire Cerclage. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$1,248associated payments (2023-2025)
9clinicians with associated payments
1company reporting

By year

2023 $1,248

Payments reported as associated with Shoulder Suture Fiberwire Cerclage, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Thoracic Surgery (Cardiothoracic Vascular Surgery) $1,248

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Shoulder Suture Fiberwire Cerclage

These are the largest totals companies reported as associated with Shoulder Suture Fiberwire Cerclage. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Patrick Rudersdorf Lakewood, CO Thoracic Surgery (Cardiothoracic Vascular Surgery) $415.25
Ashok Venkataraman Chapel Hill, NC Thoracic Surgery (Cardiothoracic Vascular Surgery) $192.68
Paul Digiorgi Port Charlotte, FL Thoracic Surgery (Cardiothoracic Vascular Surgery) $159.75
Marc Gerdisch Indianapolis, IN Thoracic Surgery (Cardiothoracic Vascular Surgery) $113.43
Daniel Engelman Springfield, MA Thoracic Surgery (Cardiothoracic Vascular Surgery) $106.97
Tom Nguyen Miami, FL Thoracic Surgery (Cardiothoracic Vascular Surgery) $98.33
Husam Balkhy Chicago, IL Thoracic Surgery (Cardiothoracic Vascular Surgery) $53.93
Rawn Salenger Towson, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) $53.93
Thomas Schwann Royal Oak, MI Thoracic Surgery (Cardiothoracic Vascular Surgery) $53.93

Prescribed Shoulder Suture Fiberwire Cerclage?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.